“…Testing Enro‐C to treat leptospirosis appears to be desirable based on the clinical efficacy observed for other antibacterial drugs. The existence of a high probability of failure to achieve bacteriological cure with streptomycin, the preference drug to date, has been recognized (Gerritsen, Koopmans, Dekker, De Jong, & Olyhoek, ; Gerritsen, Koopmans, & Olyhoek, ). Other antimicrobial drugs such as amoxicillin (Smith et al., ), oxytetracycline, tilmicosin, and ceftiofur (Alt et al., ) have been tested, in which low efficiencies have been reported and, as indicated above, fluoroquinolones are not particularly effective in the treatment of leptospirosis in veterinary medicine (Griffith et al, ; Mauro & Harkin, ; Wu et al., ).…”